GlassScriptPhysician profile
Ishrat Rafi
NPI 1861451254
$29,453.87
in general payments reported to CMS, 2019-2025
21 companies · $4,346 in 2025
The $4,346 reported for 2025 was more than what 97% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,117 · 2020: $641 · 2021: $599 · 2022: $5,087 · 2023: $12K · 2024: $2,461 · 2025: $4,346.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $17K · Food and Beverage: $1,586 · Travel and Lodging: $172.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $17,252.50 |
| Food and Beverage | $1,586.37 |
| Travel and Lodging | $171.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $22,218.41 | 2022-2025 | Veozah |
| Intuitive Surgical, INC. | $2,334.65 | 2019-2022 | |
| Olympus Corporation of The Americas | $889.64 | 2019 | |
| Baxter Healthcare | $674.72 | 2021-2025 | Tisseel |
| Applied Medical Resources Corporation | $588.01 | 2020 | |
| Covidien LP | $514.34 | 2019 | |
| Hologic Sales and Service, LLC | $500.23 | 2019-2025 | Acessa Provu System, Novasure, Myosure Tissue Removal Device |
| Ethicon US, LLC | $365.76 | 2019-2022 | |
| Minerva Surgical, INC | $259.08 | 2022-2024 | |
| Conmed Corporation | $201.47 | 2019 | |
| Biogen, INC. | $125.00 | 2025 | Zurzuvae |
| Pacira Pharmaceuticals Incorporated | $124.92 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $116.64 | 2022 | |
| Medtronic USA, INC. | $112.64 | 2019-2020 | |
| Coopersurgical, INC. | $110.97 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $107.10 | 2023 | Myfembree |
| Stryker Corporation | $106.18 | 2023 | Spy-Phi System |
| Mallinckrodt Enterprises LLC | $38.16 | 2019 | |
| Medtronic, INC. | $29.05 | 2022 | |
| Momentis Surgical INC. | $26.00 | 2022 | |
| Acell, INC. | $10.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ishrat Rafi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.